BACKGROUND: Cancer patients at the end of life take numerous medications. However, it has not been assessed what proportion of patients take unnecessary medications and which patients are at risk for doing so. METHODS: Cross-sectional survey of medications utilized by terminally ill ambulatory cancer patients, with the aim of identifying medications considered unnecessary as per explicit criteria. The criteria took into account whether drugs could benefit patients with terminal cancer. RESULTS: Among 87 patients, 21 (24%, 95% confidence interval [CI] 15.6-34.5%) were taking at least one unnecessary medication, the most common being gastric protectors. In multivariable analyses, patients with Charlson Comobidity Index≤1 (OR: 4.49, CI95% 1.32-15.26; p=0.01) or whose medication list had not been reconciled by physicians (OR: 6.38, CI95% 1.21-33.40; p=0.02) were more likely to use an unnecessary medication. CONCLUSION: Patients with advanced cancer take many medications considered unnecessary. Medication reconciliation should be performed routinely for these patients.
BACKGROUND:Cancerpatients at the end of life take numerous medications. However, it has not been assessed what proportion of patients take unnecessary medications and which patients are at risk for doing so. METHODS: Cross-sectional survey of medications utilized by terminally ill ambulatory cancerpatients, with the aim of identifying medications considered unnecessary as per explicit criteria. The criteria took into account whether drugs could benefit patients with terminal cancer. RESULTS: Among 87 patients, 21 (24%, 95% confidence interval [CI] 15.6-34.5%) were taking at least one unnecessary medication, the most common being gastric protectors. In multivariable analyses, patients with Charlson Comobidity Index≤1 (OR: 4.49, CI95% 1.32-15.26; p=0.01) or whose medication list had not been reconciled by physicians (OR: 6.38, CI95% 1.21-33.40; p=0.02) were more likely to use an unnecessary medication. CONCLUSION:Patients with advanced cancer take many medications considered unnecessary. Medication reconciliation should be performed routinely for these patients.
Authors: Michael D Cantor; Clarence H Braddock; Arthur R Derse; Denise Murray Edwards; Gerald L Logue; William Nelson; Angela M Prudhomme; Robert A Pearlman; James E Reagan; Ginger Schafer Wlody; Ellen Fox Journal: Arch Intern Med Date: 2003 Dec 8-22
Authors: E S T Samano; L M Ribeiro; A S Campos; F Lewin; E S V Filho; P T Goldenstein; L J M Costa; A del Giglio Journal: Eur J Cancer Care (Engl) Date: 2005-05 Impact factor: 2.520
Authors: N J H Raijmakers; L van Zuylen; C J Furst; M Beccaro; L Maiorana; P Pilastri; C Rossi; G Flego; A van der Heide; M Costantini Journal: Support Care Cancer Date: 2012-10-14 Impact factor: 3.603
Authors: Yasamin A Jodat; Min G Kang; Kiavash Kiaee; Gyeong J Kim; Angel F H Martinez; Aliza Rosenkranz; Hojae Bae; Su R Shin Journal: Curr Pharm Des Date: 2018 Impact factor: 3.116
Authors: Justin P Turner; Sepehr Shakib; Nimit Singhal; Jonathon Hogan-Doran; Robert Prowse; Sally Johns; J Simon Bell Journal: Support Care Cancer Date: 2014-03-02 Impact factor: 3.603
Authors: Julian Lindsay; Michael Dooley; Jennifer Martin; Michael Fay; Alison Kearney; Michael Barras Journal: Support Care Cancer Date: 2013-12-21 Impact factor: 3.603